Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Label/Quencher-Free Detection of Exon Deletion Mutation in Epidermal Growth Factor Receptor Gene Using G-Quadruplex-Inducing DNA Probe

  • Kim, Hyo Ryoung (Department of Bioscience and Biotechnology, Konkuk University) ;
  • Lee, Il Joon (Department of Bioscience and Biotechnology, Konkuk University) ;
  • Kim, Dong-Eun (Department of Bioscience and Biotechnology, Konkuk University)
  • Received : 2016.10.12
  • Accepted : 2016.10.26
  • Published : 2017.01.28
Download PDF
⟨ Previous Next ⟩

Abstract

Detection of exon 19 deletion mutation in the epidermal growth factor receptor (EGFR) gene, which results in increased and sustained phosphorylation of EGFR, is important for diagnosis and treatment guidelines in non-small-cell lung cancer. Here, we have developed a simple and convenient detection system using the interaction between G-quadruplex and fluorophore thioflavin T (ThT) for discriminating EGFR exon 19 deletion mutant DNA from wild type without a label and quencher. In the presence of exon 19 deletion mutant DNA, the probe DNAs annealed to the target sequences were transformed into G-quadruplex structure. Subsequent intercalation of ThT into the G-quadruplex resulted in a light-up fluorescence signal, which reflects the amount of mutant DNA. Due to stark differences in fluorescence intensity between mutant and wild-type DNA, we suggest that the induced G-quadruplex structure in the probe DNA can report the presence of cancer-causing deletion mutant DNAs with high sensitivity.

Keywords

References

  1. Jemal A, Clegg LX, Ward E, Ries LA, Wu X, Jamison PM, et al. 2004. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 101: 3-27. https://doi.org/10.1002/cncr.20288
  2. DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. 2014. Cancer treatment and survivorship statistics, 2014. CA Cancer J. Clin. 64: 252-271. https://doi.org/10.3322/caac.21235
  3. Mitsudomi T, Yatabe Y. 2010. Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer. FEBS J. 277: 301-308. https://doi.org/10.1111/j.1742-4658.2009.07448.x
  4. Piotrowska Z, Sequist LV. 2015. Epidermal growth factor receptor-mutant lung cancer: new drugs, new resistance mechanisms, and future treatment options. Cancer J. 21: 371-377. https://doi.org/10.1097/PPO.0000000000000147
  5. Riely GJ, Politi KA, Miller VA, Pao W. 2006. Update on epidermal growth factor receptor mutations in non-small cell lung cancer. Clin. Cancer Res. 12: 7232-7241. https://doi.org/10.1158/1078-0432.CCR-06-0658
  6. Sharma SV, Bell DW, Settleman J, Haber DA. 2007. Epidermal growth factor receptor mutations in lung cancer. Nat. Rev. Cancer 7: 169-181. https://doi.org/10.1038/nrc2088
  7. Huang S-M, Harari PM. 1999. Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preliminary clinical results. Invest. New Drugs 17: 259-269. https://doi.org/10.1023/A:1006384521198
  8. Yatabe Y, Hida T, Horio Y, Kosaka T, Takahashi T, Mitsudomi T. 2006. A rapid, sensitive assay to detect EGFR mutation in small biopsy specimens from lung cancer. J. Mol. Diagn. 8: 335-341. https://doi.org/10.2353/jmoldx.2006.050104
  9. Jänne PA, Borras AM, Kuang Y, Rogers AM, Joshi VA, Liyanage H, et al. 2006. A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening. Clin. Cancer Res. 12: 751-758. https://doi.org/10.1158/1078-0432.CCR-05-2047
  10. Kimura H, Fujiwara Y, Sone T, Kunitoh H, Tamura T, Kasahara K, Nishio K. 2006. High sensitivity detection of epidermal growth factor receptor mutations in the pleural effusion of non-small cell lung cancer patients. Cancer Sci. 97: 642-648. https://doi.org/10.1111/j.1349-7006.2006.00216.x
  11. Ellison G, Zhu G, Moulis A, Dearden S, Speake G, McCormack R. 2013. EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples. J. Clin. Pathol. 66: 79-89. https://doi.org/10.1136/jclinpath-2012-201194
  12. Li T, Wang E, Dong S. 2009. G-Quadruplex-based DNAzyme as a sensing platform for ultrasensitive colorimetric potassium detection. Chem. Commun. 580-582.
  13. Balasubramanian S, Hurley LH, Neidle S. 2011. Targeting Gquadruplexes in gene promoters: a novel anticancer strategy? Nat. Rev. Drug Discov. 10: 261-275. https://doi.org/10.1038/nrd3428
  14. Deng M, Zhang D, Zhou Y, Zhou X. 2008. Highly effective colorimetric and visual detection of nucleic a cids using an asymmetrically split peroxidase DNAzyme. J. Am. Chem. Soc. 130: 13095-13102. https://doi.org/10.1021/ja803507d
  15. Kolpashchikov DM. 2008. Split DNA enzyme for visual single nucleotide polymorphism typing. J. Am. Chem. Soc. 130: 2934-2935. https://doi.org/10.1021/ja711192e
  16. Mohanty J, Barooah N, Dhamodharan V, Harikrishna S, Pradeepkumar P, Bhasikuttan AC. 2012. Thioflavin T as an efficient inducer and selective fluorescent sensor for the human telomeric G-quadruplex DNA. J. Am. Chem. Soc. 135: 367-376.

Cited by

  1. Overexpression of the Bacillus licheniformis GroES enhances thermotolerance of Bacillus subtilis WB600 vol.32, pp.6, 2017, https://doi.org/10.1080/13102818.2018.1517029
  2. G-Quadruplexes as An Alternative Recognition Element in Disease-Related Target Sensing vol.24, pp.6, 2017, https://doi.org/10.3390/molecules24061079